Autoimmune polyendocrine syndrome: Difference between revisions
No edit summary |
No edit summary |
||
Line 17: | Line 17: | ||
{{CMG}} | {{CMG}} | ||
{{SK}} Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy syndrome | {{SK}} Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy syndrome; polyglandular autoimmune syndrome type 1; APS1 | ||
==[[Autoimmune polyendocrine syndrome overview|Overview]]== | ==[[Autoimmune polyendocrine syndrome overview|Overview]]== |
Revision as of 13:18, 20 September 2012
For patient information click here
Autoimmune polyendocrine syndrome | |
ICD-10 | E31.0 |
---|---|
OMIM | 240300 269200 |
DiseasesDB | 29212 Template:DiseasesDB2 |
Autoimmune polyendocrine syndrome Microchapters |
Differentiating Autoimmune polyendocrine syndrome from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Autoimmune polyendocrine syndrome On the Web |
American Roentgen Ray Society Images of Autoimmune polyendocrine syndrome |
Directions to Hospitals Treating Autoimmune polyendocrine syndrome |
Risk calculators and risk factors for Autoimmune polyendocrine syndrome |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Synonyms and keywords: Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy syndrome; polyglandular autoimmune syndrome type 1; APS1
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Autoimmune polyendocrine syndrome from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms | Physical Examination | Laboratory Findings | Electrocardiogram | Chest X Ray | CT | MRI | Ultrasound | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies